158 related articles for article (PubMed ID: 9491638)
1. [Bone metastases: pathogenesis and treatment with diphosphonates].
Body JJ
Bull Mem Acad R Med Belg; 1997; 152(3):169-74; discussion 174-6. PubMed ID: 9491638
[TBL] [Abstract][Full Text] [Related]
2. Bone metastases and tumor-induced hypercalcemia.
Body JJ
Curr Opin Oncol; 1992 Aug; 4(4):624-31. PubMed ID: 1511019
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR
J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902
[TBL] [Abstract][Full Text] [Related]
4. Response to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein.
Walls J; Ratcliffe WA; Howell A; Bundred NJ
Br J Cancer; 1994 Jul; 70(1):169-72. PubMed ID: 8018531
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone-related protein (PTHrP)-(1-139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo.
Guise TA; Yin JJ; Thomas RJ; Dallas M; Cui Y; Gillespie MT
Bone; 2002 May; 30(5):670-6. PubMed ID: 11996903
[TBL] [Abstract][Full Text] [Related]
6. Role of parathyroid hormone-related peptide in hypercalcemia of malignancy and the development of osteolytic metastases.
de Vernejoul MC
Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):119S-123S. PubMed ID: 9273953
[No Abstract] [Full Text] [Related]
7. Circulating PTH and PTHrP levels before and after treatment of tumor induced hypercalcemia with Pamidronate Disodium (APD).
Grill V; Murray RM; Ho PW; Santamaria JD; Pitt P; Potts C; Jerums G; Martin TJ
J Clin Endocrinol Metab; 1992 Jun; 74(6):1468-70. PubMed ID: 1592895
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia.
Gurney H; Grill V; Martin TJ
Lancet; 1993 Jun; 341(8861):1611-3. PubMed ID: 8099988
[TBL] [Abstract][Full Text] [Related]
9. Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.
Fraser WD; Logue FC; Gallacher SJ; O'Reilly DS; Beastall GH; Ralston SH; Boyle IT
Bone Miner; 1991 Feb; 12(2):113-21. PubMed ID: 1849762
[TBL] [Abstract][Full Text] [Related]
10. [Hypercalcemia and malignancies; pathogenesis, differential diagnosis and treatment].
Slee PH; Koppeschaar HP; Nortier JW; Raymakers JA
Ned Tijdschr Geneeskd; 1992 Jun; 136(26):1243-7. PubMed ID: 1620252
[No Abstract] [Full Text] [Related]
11. [Tumorous osteopathy and tumorous hypercalcemia].
ThiƩbaud D; Burckhardt P
Internist (Berl); 1990 Dec; 31(12):756-62. PubMed ID: 2289865
[No Abstract] [Full Text] [Related]
12. [PTHrP and breast cancer].
Devys A; Lortholary A; Audran M
Bull Cancer; 2001 Nov; 88(11):1075-80. PubMed ID: 11741801
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates in the treatment of malignant bone disease.
Berenson JR; Lipton A
Annu Rev Med; 1999; 50():237-48. PubMed ID: 10073275
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone-related protein(50-69) and response to pamidronate therapy for tumour-induced hypercalcaemia.
Dodwell DJ; Abbas SK; Morton AR; Howell A
Eur J Cancer; 1991; 27(12):1629-33. PubMed ID: 1782072
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone related protein.
Heath DA
Clin Endocrinol (Oxf); 1993 Feb; 38(2):135-6. PubMed ID: 8435893
[No Abstract] [Full Text] [Related]
16. [Bone targeting agents: bisphosphonates].
Debiais F
Bull Cancer; 2013 Nov; 100(11):1199-206. PubMed ID: 24158668
[TBL] [Abstract][Full Text] [Related]
17. Bone and cancer: pathophysiology and treatment of metastases.
Kanis JA
Bone; 1995 Aug; 17(2 Suppl):101S-105S. PubMed ID: 8579890
[TBL] [Abstract][Full Text] [Related]
18. Association between histomorphometry and biochemical markers of bone turnover in a longitudinal rat model of parathyroid hormone-related peptide (PTHrP)-mediated tumor osteolysis.
Juraschek M; Seibel MJ; Woitge HW; Krempien B; Bauss F
Bone; 2000 May; 26(5):475-83. PubMed ID: 10773587
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of breast cancer metastases to bone.
Guise TA; Kozlow WM; Heras-Herzig A; Padalecki SS; Yin JJ; Chirgwin JM
Clin Breast Cancer; 2005 Feb; 5 Suppl(2):S46-53. PubMed ID: 15807924
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates as cancer drugs.
Mundy GR
Hosp Pract (1995); 1999 May; 34(5):81-4, 88-9, 93-4. PubMed ID: 10340036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]